Related Articles

• Predictive value of baseline ¹⁸F‑FDG PET/CT and interim treatment response for the prognosis of patients with diffuse large B‑cell lymphoma receiving R‑CHOP chemotherapy
• Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
• Metabolic tumor volume changes assessed by interval 18fluorodeoxyglucose positron emission tomography‑computed tomography for the prediction of complete response and survival in patients with diffuse large B‑cell lymphoma
• Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study
• A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy